Pre-order Enquiry
Request Free Sample
Global Ketorolac Market Research Report 2020
SKU ID : QYR-15294861 | Publishing Date : 17-Feb-2020 | No. of pages : 124
Detailed TOC of Global Ketorolac Market Research Report 2020
Table of Contents1 Ketorolac Market Overview
1.1 Product Overview and Scope of Ketorolac
1.2 Ketorolac Segment by Type
1.2.1 Global Ketorolac Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tables
1.2.3 Injection
1.2.4 Other
1.3 Ketorolac Segment by Application
1.3.1 Ketorolac Sales Comparison by Application: 2020 VS 2026
1.3.2 Medical Uses
1.3.3 Chemistry Uses
1.3.4 Other
1.4 Global Ketorolac Market Size Estimates and Forecasts
1.4.1 Global Ketorolac Revenue 2015-2026
1.4.2 Global Ketorolac Sales 2015-2026
1.4.3 Ketorolac Market Size by Region: 2020 Versus 2026
2 Global Ketorolac Market Competition by Manufacturers
2.1 Global Ketorolac Sales Market Share by Manufacturers (2015-2020)
2.2 Global Ketorolac Revenue Share by Manufacturers (2015-2020)
2.3 Global Ketorolac Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Ketorolac Manufacturing Sites, Area Served, Product Type
2.5 Ketorolac Market Competitive Situation and Trends
2.5.1 Ketorolac Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Ketorolac Players (Opinion Leaders)
3 Ketorolac Retrospective Market Scenario by Region
3.1 Global Ketorolac Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Ketorolac Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Ketorolac Market Facts & Figures by Country
3.3.1 North America Ketorolac Sales by Country
3.3.2 North America Ketorolac Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ketorolac Market Facts & Figures by Country
3.4.1 Europe Ketorolac Sales by Country
3.4.2 Europe Ketorolac Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ketorolac Market Facts & Figures by Region
3.5.1 Asia Pacific Ketorolac Sales by Region
3.5.2 Asia Pacific Ketorolac Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ketorolac Market Facts & Figures by Country
3.6.1 Latin America Ketorolac Sales by Country
3.6.2 Latin America Ketorolac Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Ketorolac Market Facts & Figures by Country
3.7.1 Middle East and Africa Ketorolac Sales by Country
3.7.2 Middle East and Africa Ketorolac Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Ketorolac Historic Market Analysis by Type
4.1 Global Ketorolac Sales Market Share by Type (2015-2020)
4.2 Global Ketorolac Revenue Market Share by Type (2015-2020)
4.3 Global Ketorolac Price Market Share by Type (2015-2020)
4.4 Global Ketorolac Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Ketorolac Historic Market Analysis by Application
5.1 Global Ketorolac Sales Market Share by Application (2015-2020)
5.2 Global Ketorolac Revenue Market Share by Application (2015-2020)
5.3 Global Ketorolac Price by Application (2015-2020)
6 Company Profiles and Key Figures in Ketorolac Business
6.1 Allergan
6.1.1 Corporation Information
6.1.2 Allergan Description, Business Overview and Total Revenue
6.1.3 Allergan Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Allergan Products Offered
6.1.5 Allergan Recent Development
6.2 DeepCare Health
6.2.1 DeepCare Health Ketorolac Production Sites and Area Served
6.2.2 DeepCare Health Description, Business Overview and Total Revenue
6.2.3 DeepCare Health Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.2.4 DeepCare Health Products Offered
6.2.5 DeepCare Health Recent Development
6.3 Cadila
6.3.1 Cadila Ketorolac Production Sites and Area Served
6.3.2 Cadila Description, Business Overview and Total Revenue
6.3.3 Cadila Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Cadila Products Offered
6.3.5 Cadila Recent Development
6.4 FDC
6.4.1 FDC Ketorolac Production Sites and Area Served
6.4.2 FDC Description, Business Overview and Total Revenue
6.4.3 FDC Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.4.4 FDC Products Offered
6.4.5 FDC Recent Development
6.5 Intas Laboratories
6.5.1 Intas Laboratories Ketorolac Production Sites and Area Served
6.5.2 Intas Laboratories Description, Business Overview and Total Revenue
6.5.3 Intas Laboratories Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Intas Laboratories Products Offered
6.5.5 Intas Laboratories Recent Development
6.6 Gufic Chem
6.6.1 Gufic Chem Ketorolac Production Sites and Area Served
6.6.2 Gufic Chem Description, Business Overview and Total Revenue
6.6.3 Gufic Chem Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Gufic Chem Products Offered
6.6.5 Gufic Chem Recent Development
6.7 Ranbaxy
6.6.1 Ranbaxy Ketorolac Production Sites and Area Served
6.6.2 Ranbaxy Description, Business Overview and Total Revenue
6.6.3 Ranbaxy Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ranbaxy Products Offered
6.7.5 Ranbaxy Recent Development
6.8 Adley Formulation
6.8.1 Adley Formulation Ketorolac Production Sites and Area Served
6.8.2 Adley Formulation Description, Business Overview and Total Revenue
6.8.3 Adley Formulation Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Adley Formulation Products Offered
6.8.5 Adley Formulation Recent Development
6.9 Neon Laboratories
6.9.1 Neon Laboratories Ketorolac Production Sites and Area Served
6.9.2 Neon Laboratories Description, Business Overview and Total Revenue
6.9.3 Neon Laboratories Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Neon Laboratories Products Offered
6.9.5 Neon Laboratories Recent Development
6.10 Sun Pharmaceutical Industries
6.10.1 Sun Pharmaceutical Industries Ketorolac Production Sites and Area Served
6.10.2 Sun Pharmaceutical Industries Description, Business Overview and Total Revenue
6.10.3 Sun Pharmaceutical Industries Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Sun Pharmaceutical Industries Products Offered
6.10.5 Sun Pharmaceutical Industries Recent Development
6.11 Cipla
6.11.1 Cipla Ketorolac Production Sites and Area Served
6.11.2 Cipla Ketorolac Description, Business Overview and Total Revenue
6.11.3 Cipla Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Cipla Products Offered
6.11.5 Cipla Recent Development
6.12 Dallas Pharmaceuticals
6.12.1 Dallas Pharmaceuticals Ketorolac Production Sites and Area Served
6.12.2 Dallas Pharmaceuticals Ketorolac Description, Business Overview and Total Revenue
6.12.3 Dallas Pharmaceuticals Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Dallas Pharmaceuticals Products Offered
6.12.5 Dallas Pharmaceuticals Recent Development
6.13 Nicholas Piramal India
6.13.1 Nicholas Piramal India Ketorolac Production Sites and Area Served
6.13.2 Nicholas Piramal India Ketorolac Description, Business Overview and Total Revenue
6.13.3 Nicholas Piramal India Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Nicholas Piramal India Products Offered
6.13.5 Nicholas Piramal India Recent Development
6.14 AHPL
6.14.1 AHPL Ketorolac Production Sites and Area Served
6.14.2 AHPL Ketorolac Description, Business Overview and Total Revenue
6.14.3 AHPL Ketorolac Sales, Revenue and Gross Margin (2015-2020)
6.14.4 AHPL Products Offered
6.14.5 AHPL Recent Development
7 Ketorolac Manufacturing Cost Analysis
7.1 Ketorolac Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ketorolac
7.4 Ketorolac Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ketorolac Distributors List
8.3 Ketorolac Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Ketorolac Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ketorolac by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Ketorolac by Type (2021-2026)
10.2 Ketorolac Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ketorolac by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Ketorolac by Application (2021-2026)
10.3 Ketorolac Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ketorolac by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Ketorolac by Region (2021-2026)
10.4 North America Ketorolac Estimates and Projections (2021-2026)
10.5 Europe Ketorolac Estimates and Projections (2021-2026)
10.6 Asia Pacific Ketorolac Estimates and Projections (2021-2026)
10.7 Latin America Ketorolac Estimates and Projections (2021-2026)
10.8 Middle East and Africa Ketorolac Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Ketorolac Market Research Report 2020
List of TablesTable 1. Global Ketorolac Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Ketorolac Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Ketorolac Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Ketorolac Manufacturers Covered in This Study
Table 5. Global Ketorolac Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Ketorolac Sales Share by Manufacturers (2015-2020)
Table 7. Global Ketorolac Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Ketorolac Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Ketorolac Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Ketorolac Sales Sites and Area Served
Table 11. Manufacturers Ketorolac Product Types
Table 12. Global Ketorolac Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ketorolac by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ketorolac as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Ketorolac Players
Table 16. Global Ketorolac Sales (K MT) by Region (2015-2020)
Table 17. Global Ketorolac Sales Market Share by Region (2015-2020)
Table 18. Global Ketorolac Revenue (Million US$) by Region (2015-2020)
Table 19. Global Ketorolac Revenue Market Share by Region (2015-2020)
Table 20. North America Ketorolac Sales by Country (2015-2020) (K MT)
Table 21. North America Ketorolac Sales Market Share by Country (2015-2020)
Table 22. North America Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Ketorolac Revenue Market Share by Country (2015-2020)
Table 24. Europe Ketorolac Sales by Country (2015-2020) (K MT)
Table 25. Europe Ketorolac Sales Market Share by Country (2015-2020)
Table 26. Europe Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Ketorolac Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Ketorolac Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Ketorolac Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Ketorolac Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Ketorolac Revenue Market Share by Region (2015-2020)
Table 32. Latin America Ketorolac Sales by Country (2015-2020) (K MT)
Table 33. Latin America Ketorolac Sales Market Share by Country (2015-2020)
Table 34. Latin America Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Ketorolac Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Ketorolac Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Ketorolac Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Ketorolac Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Ketorolac Revenue Market Share by Country (2015-2020)
Table 40. Global Ketorolac Sales (K MT) by Type (2015-2020)
Table 41. Global Ketorolac Sales Share by Type (2015-2020)
Table 42. Global Ketorolac Revenue (Million US$) by Type (2015-2020)
Table 43. Global Ketorolac Revenue Share by Type (2015-2020)
Table 44. Global Ketorolac Price (USD/MT) by Type (2015-2020)
Table 45. Global Ketorolac Sales (K MT) by Application (2015-2020)
Table 46. Global Ketorolac Sales Market Share by Application (2015-2020)
Table 47. Global Ketorolac Sales Growth Rate by Application (2015-2020)
Table 48. Allergan Ketorolac Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Allergan Main Product
Table 52. Allergan Recent Development
Table 53. DeepCare Health Ketorolac Corporation Information
Table 54. DeepCare Health Corporation Information
Table 55. DeepCare Health Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. DeepCare Health Main Product
Table 57. DeepCare Health Recent Development
Table 58. Cadila Ketorolac Corporation Information
Table 59. Cadila Corporation Information
Table 60. Cadila Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Cadila Main Product
Table 62. Cadila Recent Development
Table 63. FDC Ketorolac Corporation Information
Table 64. FDC Corporation Information
Table 65. FDC Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. FDC Main Product
Table 67. FDC Recent Development
Table 68. Intas Laboratories Ketorolac Corporation Information
Table 69. Intas Laboratories Corporation Information
Table 70. Intas Laboratories Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Intas Laboratories Main Product
Table 72. Intas Laboratories Recent Development
Table 73. Gufic Chem Ketorolac Corporation Information
Table 74. Gufic Chem Corporation Information
Table 75. Gufic Chem Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Gufic Chem Main Product
Table 77. Gufic Chem Recent Development
Table 78. Ranbaxy Ketorolac Corporation Information
Table 79. Ranbaxy Corporation Information
Table 80. Ranbaxy Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Ranbaxy Main Product
Table 82. Ranbaxy Recent Development
Table 83. Adley Formulation Ketorolac Corporation Information
Table 84. Adley Formulation Corporation Information
Table 85. Adley Formulation Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Adley Formulation Main Product
Table 87. Adley Formulation Recent Development
Table 88. Neon Laboratories Ketorolac Corporation Information
Table 89. Neon Laboratories Corporation Information
Table 90. Neon Laboratories Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Neon Laboratories Main Product
Table 92. Neon Laboratories Recent Development
Table 93. Sun Pharmaceutical Industries Ketorolac Corporation Information
Table 94. Sun Pharmaceutical Industries Corporation Information
Table 95. Sun Pharmaceutical Industries Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Sun Pharmaceutical Industries Main Product
Table 97. Sun Pharmaceutical Industries Recent Development
Table 98. Cipla Ketorolac Corporation Information
Table 99. Cipla Corporation Information
Table 100. Cipla Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Cipla Main Product
Table 102. Cipla Recent Development
Table 103. Dallas Pharmaceuticals Ketorolac Corporation Information
Table 104. Dallas Pharmaceuticals Corporation Information
Table 105. Dallas Pharmaceuticals Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Dallas Pharmaceuticals Main Product
Table 107. Dallas Pharmaceuticals Recent Development
Table 108. Nicholas Piramal India Ketorolac Corporation Information
Table 109. Nicholas Piramal India Corporation Information
Table 110. Nicholas Piramal India Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Nicholas Piramal India Main Product
Table 112. Nicholas Piramal India Recent Development
Table 113. AHPL Ketorolac Corporation Information
Table 114. AHPL Corporation Information
Table 115. AHPL Ketorolac Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. AHPL Main Product
Table 117. AHPL Recent Development
Table 118. Sales Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Ketorolac Distributors List
Table 121. Ketorolac Customers List
Table 122. Market Key Trends
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Global Ketorolac Sales (K MT) Forecast by Type (2021-2026)
Table 126. Global Ketorolac Sales Market Share Forecast by Type (2021-2026)
Table 127. Global Ketorolac Revenue (Million US$) Forecast by Type (2021-2026)
Table 128. Global Ketorolac Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 129. Global Ketorolac Sales (K MT) Forecast by Application (2021-2026)
Table 130. Global Ketorolac Revenue (Million US$) Forecast by Application (2021-2026)
Table 131. Global Ketorolac Sales (K MT) Forecast by Region (2021-2026)
Table 132. Global Ketorolac Sales Market Share Forecast by Region (2021-2026)
Table 133. Global Ketorolac Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Global Ketorolac Revenue Market Share Forecast by Region (2021-2026)
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Ketorolac
Figure 2. Global Ketorolac Sales Market Share by Type: 2020 VS 2026
Figure 3. Tables Product Picture
Figure 4. Injection Product Picture
Figure 5. Other Product Picture
Figure 6. Global Ketorolac Consumption Market Share by Application: 2020 VS 2026
Figure 7. Medical Uses
Figure 8. Chemistry Uses
Figure 9. Other
Figure 10. Global Ketorolac Market Size 2015-2026 (US$ Million)
Figure 11. Global Ketorolac Sales Capacity (K MT) (2015-2026)
Figure 12. Global Ketorolac Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Ketorolac Sales Share by Manufacturers in 2020
Figure 14. Global Ketorolac Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Ketorolac Revenue in 2019
Figure 16. Ketorolac Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Ketorolac Sales Market Share by Region (2015-2020)
Figure 18. Global Ketorolac Sales Market Share by Region in 2019
Figure 19. Global Ketorolac Revenue Market Share by Region (2015-2020)
Figure 20. Global Ketorolac Revenue Market Share by Region in 2019
Figure 21. North America Ketorolac Sales Market Share by Country in 2019
Figure 22. North America Ketorolac Revenue Market Share by Country in 2019
Figure 23. U.S. Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 24. U.S. Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 26. Canada Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Ketorolac Sales Market Share by Country in 2019
Figure 28. Europe Ketorolac Revenue Market Share by Country in 2019
Figure 29. Germany Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 30. Germany Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 32. France Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.K. Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 36. Italy Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 38. Russia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Ketorolac Sales Market Share by Region in 2019
Figure 40. Asia Pacific Ketorolac Revenue Market Share by Region in 2019
Figure 41. China Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 42. China Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 44. Japan Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 46. South Korea Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 48. India Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 50. Australia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 52. Taiwan Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 54. Indonesia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 56. Thailand Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 58. Malaysia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 60. Philippines Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 62. Vietnam Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Ketorolac Sales Market Share by Country in 2019
Figure 64. Latin America Ketorolac Revenue Market Share by Country in 2019
Figure 65. Mexico Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 66. Mexico Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 68. Brazil Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 70. Argentina Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Ketorolac Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Ketorolac Revenue Market Share by Country in 2019
Figure 73. Turkey Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 74. Turkey Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 76. Saudi Arabia Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Ketorolac Sales Growth Rate (2015-2020) (K MT)
Figure 78. U.A.E Ketorolac Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Ketorolac by Type (2015-2020)
Figure 80. Sales Market Share of Ketorolac by Type in 2019
Figure 81. Revenue Share of Ketorolac by Type (2015-2020)
Figure 82. Revenue Market Share of Ketorolac by Type in 2019
Figure 83. Global Ketorolac Sales Growth by Type (2015-2020) (K MT)
Figure 84. Global Ketorolac Sales Market Share by Application (2015-2020)
Figure 85. Global Ketorolac Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Ketorolac by Application (2015-2020)
Figure 87. Global Revenue Share of Ketorolac by Application in 2020
Figure 88. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. DeepCare Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. FDC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Intas Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Gufic Chem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Ranbaxy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Adley Formulation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Neon Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Dallas Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Nicholas Piramal India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. AHPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Price Trend of Key Raw Materials
Figure 103. Manufacturing Cost Structure of Ketorolac
Figure 104. Manufacturing Process Analysis of Ketorolac
Figure 105. Ketorolac Industrial Chain Analysis
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. North America Ketorolac Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 110. North America Ketorolac Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Ketorolac Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Ketorolac Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Ketorolac Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Ketorolac Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Ketorolac Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Ketorolac Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Ketorolac Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Ketorolac Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
Keyplayers in Global Ketorolac Market Research Report 2020
AllerganDeepCare Health
Cadila
FDC
Intas Laboratories
Gufic Chem
Ranbaxy
Adley Formulation
Neon Laboratories
Sun Pharmaceutical Industries
Cipla
Dallas Pharmaceuticals
Nicholas Piramal India
AHPL
Request Sample
Request Discount
